Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel.

Cruz-Collazo AM, Katsara O, Grafals-Ruiz N, Colon Gonzalez J, Dorta-Estremera S, Carlo VP, Chorna N, Schneider RJ, Dharmawardhane S. Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel. Mol Cancer Ther. 2024 Nov 04; 23(11):1613-1625.

View in: PubMed

subject areas

Animals
Apoptosis
Carbon
Cell Line, Tumor
Cell Proliferation
Female
Humans
Mice
Mice, Inbred BALB C
Paclitaxel
rac GTP-Binding Proteins
Xenograft Model Antitumor Assays

authors with profiles

Suranganie Dharmawardhane

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support